Abstract
The xenotopic expression of mitochondrial alternative oxidase (AOX) has been related to a partial or total reversal of mitochondrial dysfunction in several animal models, whether exclusive mitochondrial dysfunction or diseases where ROS production may be a supporting factor. In this way, AOX is increasingly described as a candidate for human therapies. AOX is a mitochondrial inner membran…